These new medicines are called GLP-1 injections, and they work by making you feel full faster and keeping you satisfied longer
Product Highlights Brightens and Evens Skin Tone: Reduces the appearance of dark spots and hyperpigmentation for a more radiant complexion
It also leads to increased body fat, particularly in the visceral compartment, decreased memory and cognitive function, decreased deep (slow-wave) sleep, and increased sleep disorders
Start your intake How GLP-1 Medications Trigger Gastrointestinal Changes GLP-1 receptor agonists work by slowing gastric emptying and enhancing intestinal glucose-dependent secretion of insulin
Morley adds, Despite vast increases in the number of products and competitors expected to enter the GLP-1R market, sales attributed to the 14 companies other than Eli Lilly and Novo Nordisk are forecast to generate only $8.8 billion in 2030, 15 times less than the combined valuation of the two leading companies. Amgen, the company ranked third in terms of GLP-1R sales in 2030, is forecast to generate only $3 billion, driven entirely by the product maridebart cafraglutide, which is currently in Phase II for type 2 diabetes and obesity